These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31839996)

  • 1. Japanese encephalitis vaccine-specific envelope protein E138K mutation does not attenuate virulence of West Nile virus.
    Kaiser JA; Luo H; Widen SG; Wood TG; Huang CY; Wang T; Barrett ADT
    NPJ Vaccines; 2019; 4():50. PubMed ID: 31839996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
    Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
    J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design.
    Yamshchikov V; Manuvakhova M; Rodriguez E
    Virology; 2016 Jan; 487():198-206. PubMed ID: 26545140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
    Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
    Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
    Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence determinants of West Nile virus: how can these be used for vaccine design?
    Kaiser JA; Wang T; Barrett AD
    Future Virol; 2017 May; 12(5):283-295. PubMed ID: 28919920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y
    Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.
    Zhao Z; Date T; Li Y; Kato T; Miyamoto M; Yasui K; Wakita T
    J Gen Virol; 2005 Aug; 86(Pt 8):2209-2220. PubMed ID: 16033968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a human live attenuated West Nile infectious DNA vaccine: Identification of a minimal mutation set conferring the attenuation level acceptable for a human vaccine.
    Yamshchikov V; Manuvakhova M; Rodriguez E; Hébert C
    Virology; 2017 Jan; 500():122-129. PubMed ID: 27816638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14.
    Huang R; Leng S; Feng Y; Tang L; Yuan L; Yang J
    Can J Infect Dis Med Microbiol; 2019; 2019():9179308. PubMed ID: 30944684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein.
    Nath B; Gupta A; Khan SA; Kumar S
    Microb Pathog; 2017 Oct; 111():187-192. PubMed ID: 28867626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
    Lee E; Hall RA; Lobigs M
    J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity.
    Davis EH; Beck AS; Li L; White MM; Greenberg MB; Thompson JK; Widen SG; Barrett ADT; Bourne N
    NPJ Vaccines; 2021 Sep; 6(1):112. PubMed ID: 34475404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
    Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
    Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.
    Li N; Zhang ZR; Zhang YN; Liu J; Deng CL; Shi PY; Yuan ZM; Ye HQ; Zhang B
    NPJ Vaccines; 2020; 5(1):73. PubMed ID: 32802412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.